Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor cell recognition by natural killer cells.

Eric O Long1

  • 1Laboratory of Immunogenetics, NIAID, NIH, Rockville, MD 20852, USA. Elong@nih.gov

Seminars in Cancer Biology
|April 3, 2002
PubMed
Summary

Natural killer (NK) cells target cancer and virus-infected cells by recognizing cells with low HLA class I expression. This immune response is mediated by inhibitory and activating receptors, including NKG2D, which binds to ligands on tumor cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using peptide-exchange systems to interrogate peptide-specific KIR binding to HLA Class I.

Discovery immunology·2026
Same author

The fetal trophoblast cell marker HLA-G activates a type I interferon response in primary NK cells through the receptor KIR2DL4.

Science signaling·2026
Same author

Peptide-specific natural killer cell receptors.

Oxford open immunology·2025
Same author

The peptide selectivity model: Interpreting NK cell KIR-HLA-I binding interactions and their associations to human diseases.

Trends in immunology·2024
Same author

Identification and structural characterization of a mutant KRAS-G12V specific TCR restricted by HLA-A3.

European journal of immunology·2024
Same author

Autoantibodies inhibit Plasmodium falciparum growth and are associated with protection from clinical malaria.

Immunity·2024

Area of Science:

  • Immunology
  • Cellular Biology
  • Cancer Research

Background:

  • Natural killer (NK) cells are crucial for immune defense against viral infections and cancer.
  • NK cell activity is regulated by inhibitory receptors recognizing Human Leukocyte Antigen (HLA) class I molecules.
  • Tumor cells often evade immune detection by downregulating HLA class I expression.

Purpose of the Study:

  • To elucidate the mechanisms by which NK cells recognize and eliminate tumor cells.
  • To investigate the role of specific NK cell receptors in targeting cancer cells with altered HLA class I expression.

Main Methods:

  • Analysis of NK cell inhibitory receptor repertoire and specificity.
  • Investigation of NK cell activation pathways.
  • Characterization of NKG2D receptor-ligand interactions on tumor cells.

Main Results:

  • NK cells utilize inhibitory receptors with diverse HLA class I specificities to identify target cells.
  • The clonal distribution of these receptors enables recognition of tumor cells losing single HLA-B or HLA-C allotypes.
  • The activation receptor NKG2D, present on all NK cells, binds to inducible ligands expressed on tumor cells, contributing to target recognition.

Conclusions:

  • NK cell-mediated immunity against cancer and viruses relies on a balance of inhibitory and activating receptor signaling.
  • Downregulation of HLA class I on target cells is a key trigger for NK cell-mediated cytotoxicity.
  • NKG2D plays a significant role in NK cell recognition of tumor cells through its interaction with inducible ligands.

Related Experiment Videos